Loss of Myelin-Associated Glycoprotein in Kearns-Sayre Syndrome
Archives of Neurology · 01.04.2012 · 69 (4) · 490
DOI: 10.1001/archneurol.2011.2167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Neurology, erschienen am 01.04.2012. Verfasst von Nichola Z Lax und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mitochondrial Research Group, Institute for Aging and Health, Newcastle University, Framlington Place, Newcastle upon Tyne, United Kingdom. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
OBJECTIVE: To explore myelin components and mitochondrial changes within the central nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or mitochondrial DNA (mtDNA) mutations. DESIGN: Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-time and long-range polymerase chain reaction were used to determine the pathogenicity of mtDNA deletions. SETTING: Department of Clinical Pathology, Columbia University Medical Center, and Newcastle Brain Tissue Resource. PATIENTS: Seventeen patients with mitochondrial disorders and 7 controls were studied from August 1, 2009, to August 1, 2010. MAIN OUTCOME MEASURE: Regions of myelin-associated glycoprotein (MAG) loss. RESULTS: Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions. CONCLUSION: Primary mitochondrial respiratory chain defects affecting the white matter, and unrelated to inflammation, are associated with MAG loss and central nervous system demyelination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mitochondrial Research Group, Institute for Aging and Health, Newcastle University, Framlington Place, Newcastle upon Tyne, United Kingdom.
Förderung
- Medical Research Council
- Wellcome Trust
Zitieren
APA
Lax, N. Z., Campbell, G. R., Reeve, A. K., Ohno, N., Zambonin, J., Blakely, E. L., Taylor, R. W., Bonilla, E., Tanji, K., DiMauro, S., Jaros, E., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2012). Loss of Myelin-Associated Glycoprotein in Kearns-Sayre Syndrome. Archives of Neurology, 69(4), 490. https://doi.org/10.1001/archneurol.2011.2167
Vancouver
Lax NZ, Campbell GR, Reeve AK, Ohno N, Zambonin J, Blakely EL, et al. Loss of Myelin-Associated Glycoprotein in Kearns-Sayre Syndrome. Archives of Neurology. 2012;69(4):490. doi:10.1001/archneurol.2011.2167
BibTeX
@article{Lax2012,
author = {Lax, Nichola Z and Campbell, Graham R and Reeve, Amy K and Ohno, Nobuhiko and Zambonin, Jessica and Blakely, Emma L and Taylor, Robert W and Bonilla, Eduardo and Tanji, Kurenai and DiMauro, Salvatore and Jaros, Evelyn and Lassmann, Hans and Turnbull, Doug M and Mahad, Don J},
title = {Loss of Myelin-Associated Glycoprotein in Kearns-Sayre Syndrome},
journal = {Archives of Neurology},
year = {2012},
volume = {69},
number = {4},
pages = {490},
doi = {10.1001/archneurol.2011.2167}
}
EUVIMED